| Product Name | MF | CAS | Details |
|---|
| Methyl 4-O-(b-D-galactopyranosyl)-D-glucopyranoside | C13H24O11 | 7216-69-5 | Details |
| Vasoactive Intestinal peptide | C147H238N44O42S | 40077-57-4 | Details |
| 3-[[6-Deoxy-2,4-bis-O-[(2Z)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]-α-L-mannopyranosyl]oxy]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1- benzopyran-4-one | C39H32O14 | 205534-17-4 | Details |
| 2-Chloro-4-sulfamoylbenzoic acid | C7H6ClNO4S | 53250-84-3 | Details |
| EPHA antibody (Tyr779/833) | Details |
| Terbinafine dimer impurity dihydrochloride | Details |
| Thieno[2,3-b]pyridine-5-carbonitrile | C8H4N2S | 21344-31-0 | Details |
| 3-(1,3-Dioxo-3,4-dihydroisoquinolin-2(1H)-yl)propanoic acid | C12H11NO4 | 75513-35-8 | Details |
| Hamster Lymphocyte antibody | Details |
| Ethyl N-(2-hydroxyethyl)-N-methylcarbamate | C6H13NO3 | 25450-10-6 | Details |
| 2,5-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-b]thiophene | C18H26B2O4S2 | 924894-85-9 | Details |
| 1-Phenyl-1H-pyrazole-4-carbaldehyde | C10H8N2O | 54605-72-0 | Details |
| Methyl 7-fluoro-1,2-benzoxazole-3-carboxylate | C9H6FNO3 | 2060053-38-3 | Details |
| 4-(1,3-Oxazol-5-yl)pyridine | C8H6N2O | 70380-75-5 | Details |
| Dovitinib Lactate | C24H29FN6O5 | 915769-50-5 | Details |
| N,6-Dimethylpyridin-2-amine | C7H10N2 | 97986-08-8 | Details |
| trans-2-(3,4-Difluoro-phenyl)-cyclopropanecarboxylic acid | C10H8F2O2 | 1006614-50-1 | Details |
| 2-Methyloctahydro-1H-pyrazino[1,2-a]pyrazine trihydrochloride | C8H20Cl3N3 | 1883347-27-0 | Details |
| 3-Thia-8-azabicyclo[3.2.1]octane 3,3-dioxide hydrochloride | C6H12ClNO2S | 2101562-66-5 | Details |
| GJB2 antibody | Details |
| Chlorobutanol | C4H7Cl3O | 57-15-8 | Details |
| ZNF512 antibody | Details |
| H-STIRLLTSL-OH | Details |
| 4-Phenylbenzaldehyde oxime | C13H11NO | 40143-27-9 | Details |
| 1,4-Diazabicyclo[2.2.2]octane-2-carbonitrile | C7H11N3 | 1394774-46-9 | Details |
| 2-{Imidazo[1,2-a]pyridin-2-ylmethoxy}benzoic acid | C15H12N2O3 | 872103-74-7 | Details |
| Octahydro-1-benzofuran-3a-carboxylic acid | C9H14O3 | 1513233-00-5 | Details |
| 8(9)-dehydrocholesterol | C27H44O | 70741-38-7 | Details |
| Cycloastragenol | C30H50O5 | 78574-94-4 | Details |
| 1-(Difluoromethyl)-1H-imidazol-2-amine | C4H5F2N3 | 2137617-28-6 | Details |
| Recombinant Influenza A HA (A/California/07/2009(H1N1)) | Details |
| 7,7-Difluoro-1-phenyl-3-azabicyclo[4.1.0]heptane hydrochloride | C12H14ClF2N | 1955515-73-7 | Details |
| 8-Boc-3,8-diazabicyclo[3.2.1]octan-2-one | C11H18N2O3 | 1622919-66-7 | Details |
| 2-[5-Amino-3-(4-chlorophenyl)-1H-pyrazol-1-yl]ethan-1-ol | C11H12ClN3O | 926188-04-7 | Details |
| 2-[(Prop-2-en-1-yl)amino]-1,3-thiazole-5-carboxylic acid | C7H8N2O2S | 1384798-69-9 | Details |
| H-IEVSQLLK^-OH | Details |
| UNCX antibody | Details |
| 6-(Acetylsulfanyl)hexanoic acid | C8H14O3S | 80441-57-2 | Details |
| 4-(1H-1,2,3,4-Tetrazol-5-yl)piperidin-4-ol hydrochloride | C6H12ClN5O | 1803589-30-1 | Details |
| RBMS2 antibody | Details |
| AquaSpark??Alkaline Phosphatase Detection Solution, Ramot at Tel-Aviv University Ltd. Patent family WO 2017/130191 | C21H25O9P | 2097410-99-4 | Details |
| 1,1-Dioxo-3,5-dihydro-2H-thieno[2,3-c]pyrrole-4-carboxylic acid | C7H7NO4S | 1554303-12-6 | Details |
| Integrin beta antibody | Details |
| Alisporivir intermediate-1 | C74H132N12O17 | 882506-05-0 | Details |
| (2-Phenylpyridin-4-yl)methanamine | C12H12N2 | 1514076-60-8 | Details |
| Kgp-in-1 hydrochloride | C19H25ClF4N4O3 | 2097865-47-7 | Details |
| 2-Chloro-N-methyl-N-[(propylcarbamoyl)methyl]acetamide | C8H15ClN2O2 | 850020-75-6 | Details |
| 2-(4-Iodo-1-propyl-1H-pyrazol-3-yl)acetic acid | C8H11IN2O2 | 1795503-02-4 | Details |
| 5-[(3-Sulfamoylphenyl)carbamoyl]thiophene-2-carboxylic acid | C12H10N2O5S2 | 1155162-41-6 | Details |
| 1-[2-(Dimethylamino)ethyl]-1h-pyrazol-4-amine | C7H14N4 | 1152939-98-4 | Details |
| 2-Chloro-N-(1-ethylpiperidin-4-yl)acetamide hydrochloride | C9H18Cl2N2O | 1049742-63-3 | Details |
| (5-Cyclopropyl-3-methyl-1,2-oxazol-4-yl)methanol | C8H11NO2 | 878204-48-9 | Details |
| [3-(4-Methyl-1H-pyrazol-1-yl)phenyl]boronic acid | C10H11BN2O2 | 1428582-36-8 | Details |
| 2-Amino-2-(2,5-dichlorophenyl)acetic acid | C8H7Cl2NO2 | 500695-97-6 | Details |
| Cytokeratin 23 antibody | Details |
| 2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)phenol | C13H16BF3O3 | 2055742-98-6 | Details |
| PPAR gamma 2 antibody | Details |
| 2-cyclohexyl-3-(9h-fluoren-12-ylmethoxycarbonylamino)propanoic acid | C23H23NO4 | 1217747-47-1 | Details |
| RR6 | C16H23NO4 | 1351758-37-6 | Details |
| 3-Cyclopropylpyrrolidine-2-carboxylic acid hydrochloride | C8H14ClNO2 | 2287260-29-9 | Details |
| 1,4,6-Trimethyl-2-oxo-1,2-dihydro-pyridine-3-carboxylic acid | C9H11NO3 | 24667-08-1 | Details |
| 9-Thia-3-azabicyclo[4.2.1]nonane hydrochloride | C7H14ClNS | 50848-31-2 | Details |
| H-KSLTYYKL-OH | Details |
| 2-Chloro-3,6,7-trimethylquinoline | C12H12ClN | 948290-47-9 | Details |
| 1,1-Dimethyl-3-oxo-1,3-dihydro-2-benzofuran-5-sulfonamide | C10H11NO4S | 17047-42-6 | Details |
| Aldol??515 nonanoate hydrochloride, Biosynth Patent: EP 2427431 and US 8940909 | C32H37ClN2O3 | 2484873-13-2 | Details |
| Donkey anti Sheep IgG (H + L) | Details |
| 2,2-Dimethyl-3-sulfamoylpropanoic acid | C5H11NO4S | 1368407-84-4 | Details |
| H-HISAENTK^-OH | Details |
| Recombinant Human GDF-11 | Details |
| SAPS1 antibody | Details |
| 4-Fluoro-3-(methoxymethyl)-1-benzothiophene-2-carboxamide | C11H10FNO2S | 1089555-96-3 | Details |
| 5-Bromo-2-methoxy-4-methylbenzaldehyde | C9H9BrO2 | 923281-67-8 | Details |
| N-(3,3-diphenylpropyl)-1-phenylcyclopentane-1-carboxamide | C27H29NO | 1023845-28-4 | Details |
| 3-O-Acetyl-1,2-O-isopropylidene-a-D-glucofuranose | C11H18O7 | 24807-96-3 | Details |
| H-LDPK-OH | Details |
| 3-[(2-Chlorophenyl)methyl]piperidin-2-one | C12H14ClNO | 1260766-37-7 | Details |
| LS-tetrasaccharide b | C37H62N2O29 | 64003-54-9 | Details |
| Disialyl-TF | C36H59N3O27 | 71764-07-3 | Details |
| 3-(4-Methoxyphenyl)-3,6-dihydro-7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one | C11H9N5O2 | 163977-51-3 | Details |
| 2-Oxo-2-phenylethyl 6-cyclopropyl-3-methyl-[1,2]oxazolo[5,4-b]pyridine-4-carboxylate | C19H16N2O4 | 1795274-20-2 | Details |
| 5-(Cyclopropyl)thiophene-2-carboxylic acid | C8H8O2S | 29481-28-5 | Details |
| GRLF1 antibody | Details |
| 2-Benzyloxybenzylamine hydrochloride | C14H16ClNO | 76813-80-4 | Details |
| tert-Butyl N-[3-(4-ethoxyphenyl)prop-2-yn-1-yl]carbamate | C16H21NO3 | 1461706-42-2 | Details |
| 3-Cyclobutylbenzoic acid | C11H12O2 | 19936-19-7 | Details |
| (2S, 3S, 4R) -1Benzyl-2- [(1S) - 1, 2- dihydroxyethyl] - 3, 4- pyrrolidinediol | Details |
| 4-Cyclopropyl-1H-1,2,3-triazole hydrochloride | C5H8ClN3 | 1909336-61-3 | Details |
| Catenin beta antibody | Details |
| DL-α-Methyltryptophan methyl ester | C13H16N2O2 | 114524-80-0 | Details |
| 2-Bromo-1-(3-phenyl-1,2-oxazol-4-yl)ethan-1-one | 131974-13-5 | Details |
| Dengue Type 1 antibody | Details |
| H-ETLLQDFR^-OH | Details |
| 9-Bromo-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-one | C11H11BrO | 72472-29-8 | Details |
| 4,4'-[Ethane-1,2-diylbis(oxy)]bis(3-methoxybenzaldehyde) | C18H18O6 | 5784-66-7 | Details |
| N1-(5-Fluoropyridin-2-yl)ethane-1,2-diamine | C7H10FN3 | 1248262-01-2 | Details |
| IgG2b Isotype Control Fc fusion protein (FITC) | Details |
| H-TQIQSVEPYTK-OH | Details |
| 5,7-Dichloro-2,3-dihydro-1-benzofuran-3-amine hydrochloride | C8H8Cl3NO | 2378501-32-5 | Details |
| 1-Hexyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-sulfonamide | C10H17N3O4S | 1538197-37-3 | Details |
| Product Total： Product Page： | ||||
| 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 | ||||